Supercritical fluid technology for drug product development:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
New York [u.a.]
Dekker
2004
|
| Schriftenreihe: | Drugs and the pharmaceutical sciences
138 |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | XIII, 666 S. Ill., graph. Darst. |
| ISBN: | 0824748050 |
Internformat
MARC
| LEADER | 00000nam a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV019825373 | ||
| 003 | DE-604 | ||
| 005 | 20100305 | ||
| 007 | t | ||
| 008 | 050530s2004 xxuad|| |||| 00||| eng d | ||
| 010 | |a 2004300574 | ||
| 020 | |a 0824748050 |9 0-8247-4805-0 | ||
| 035 | |a (OCoLC)54898181 | ||
| 035 | |a (DE-599)BVBBV019825373 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 044 | |a xxu |c US | ||
| 049 | |a DE-19 |a DE-29T | ||
| 050 | 0 | |a RS192 | |
| 082 | 0 | |a 615/.19 |2 22 | |
| 084 | |a VN 7200 |0 (DE-625)147610:253 |2 rvk | ||
| 245 | 1 | 0 | |a Supercritical fluid technology for drug product development |c ed. by Peter York ... |
| 264 | 1 | |a New York [u.a.] |b Dekker |c 2004 | |
| 300 | |a XIII, 666 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Drugs and the pharmaceutical sciences |v 138 | |
| 650 | 4 | |a Drugs - Research | |
| 650 | 4 | |a Fluides supercritiques | |
| 650 | 4 | |a Médicaments - Administration - Dispositifs - Conception | |
| 650 | 4 | |a Médicaments - Développement - Innovations | |
| 650 | 4 | |a Techniques pharmaceutiques | |
| 650 | 4 | |a aPharmaceutical technology | |
| 650 | 4 | |a aDrug development |a xTechnological innovations | |
| 650 | 4 | |a aSupercritical fluids | |
| 650 | 4 | |a aSupercritical fluid extraction | |
| 650 | 4 | |a aDrug delivery systems |a xDesign | |
| 650 | 4 | |a aDrug Evaluation | |
| 650 | 4 | |a aDrug Design | |
| 650 | 4 | |a aDrug Industry |a xorganization & administration | |
| 650 | 4 | |a aDrugs |a xResearch | |
| 650 | 0 | 7 | |a Produktentwicklung |0 (DE-588)4139402-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Überkritischer Zustand |0 (DE-588)4186602-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Wirkstofffreisetzung |0 (DE-588)4190018-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Therapeutisches System |0 (DE-588)4267580-7 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Therapeutisches System |0 (DE-588)4267580-7 |D s |
| 689 | 0 | 1 | |a Wirkstofffreisetzung |0 (DE-588)4190018-2 |D s |
| 689 | 0 | 2 | |a Produktentwicklung |0 (DE-588)4139402-1 |D s |
| 689 | 0 | 3 | |a Überkritischer Zustand |0 (DE-588)4186602-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a York, Peter |e Sonstige |4 oth | |
| 830 | 0 | |a Drugs and the pharmaceutical sciences |v 138 |w (DE-604)BV000002008 |9 138 | |
| 856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=013150563&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-013150563 | ||
Datensatz im Suchindex
| _version_ | 1804133329656610816 |
|---|---|
| adam_text | PM- B - SUPERCRITICAL FLUID TECHNOLOGY FOR DRUG PRODUCT DEVELOPMENT
EDITED BY PETER YORK UNIVERSITY OF BRADFORD BRADFORD, UNITED KINGDOM
UDAY B. KOMPELLA UNIVERSITY OF NEBRASKA OMAHA, NEBRASKA, U.SA. BORIS Y.
SHEKUNOV FERRO CORPORATION INDEPENDENCE, OHIO, U.SA. MARCEL DEKKER, INC.
NEW YORK * BASEL CONTENTS PREFACE HI CONTRIBUTORS XI PART I.
FUNDAMENTALS 1. CHEMISTRY AND MATERIALS DESIGN FOR CO 2 PROCESSING 1
JANICE L. PANZA AND ERIC J. BECKMAN 2. PHASE EQUILIBRIUM IN
SOLID-LIQUID-SUPERCRITICAL FLUID SYSTEMS 27 MAMATA MUKHOPADHYAY 3. FLUID
DYNAMICS, MASS TRANSFER, AND PARTICLE FORMATION IN SUPERCRITICAL FLUIDS
91 JERZY BALDYGA, MAREK HENCZKA, AND BORIS Y. SHEKUNOV 4. METHODS OF
PARTICLE PRODUCTION 159 GERARD CHARBIT, ELISABETH BADENS, AND OLIVIER
BOUTIN PART II. DRUG DELIVERY APPLICATIONS 5. COLLOID AND INTERFACE
SCIENCE FOR CO 2 -BASED PHARMACEUTICAL PROCESSES 213 KEITH P. JOHNSTON,
SANDRO R. P. DAROCHA, C. TED LEE, GE LI, AND MATTHEW Z. YATES IX X
CONTENTS 6. PRODUCTION OF POWDERS FOR RESPIRATORY DRUG DELIVERY 247
BORIS Y. SHEKUNOV 7. CONTROL OF PHYSICAL FORMS OF PHARMACEUTICAL
SUBSTANCES 283 ALBERT H. L. CHOW, HENRY H. Y. TONG, AND BORIS Y.
SHEKUNOV 8. SUPERCRITICAL FLUID IMPREGNATION OF POLYMERS FOR DRUG
DELIVERY 343 SERGEI G. KAZARIAN 9. FORMULATION OF CONTROLLED-RELEASE
DRUG DELIVERY SYSTEMS 367 NAGESH BANDI, CHRISTOPHER B. ROBERTS, RAM B.
GUPTA, AND UDAY B. KOMPELLA 10. PROCESSING OF BIOLOGICAL MATERIALS 411
B. L. KNUTSON AND MARAZBAN SARKARI PART III. OTHER APPLICATIONS AND
SCALE-UP ISSUES 11. ASYMMETRIC CATALYSIS IN SUPERCRITICAL FLUIDS 461
PHILIP G. JESSOP 12. ANALYTICAL AND SEMIPREPARATIVE SUPERCRITICAL FLUID
CHROMATOGRAPHY IN DRUG DISCOVERY 497 TERRY A. BERGER 13. DRUG EXTRACTION
539 M. D. LUQUE DE CASTRO, A. JURADO-LOPEZ, AND J. L. LUQUE-GARCIA 14.
DEVELOPMENT AND POTENTIAL OF CRITICAL FLUID TECHNOLOGY IN THE
NUTRACEUTICAL INDUSTRY 579 JERRY W. KING 15. SCALE-UP ISSUES FOR
SUPERCRITICAL FLUID PROCESSING IN COMPLIANCE WITH GMP 615 JEAN- YVES
CLAVIER AND MICHEL PERRUT INDEX 653
|
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV019825373 |
| callnumber-first | R - Medicine |
| callnumber-label | RS192 |
| callnumber-raw | RS192 |
| callnumber-search | RS192 |
| callnumber-sort | RS 3192 |
| callnumber-subject | RS - Pharmacy |
| classification_rvk | VN 7200 |
| ctrlnum | (OCoLC)54898181 (DE-599)BVBBV019825373 |
| dewey-full | 615/.19 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615/.19 |
| dewey-search | 615/.19 |
| dewey-sort | 3615 219 |
| dewey-tens | 610 - Medicine and health |
| discipline | Chemie / Pharmazie Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02478nam a2200625zcb4500</leader><controlfield tag="001">BV019825373</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20100305 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">050530s2004 xxuad|| |||| 00||| eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a">2004300574</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0824748050</subfield><subfield code="9">0-8247-4805-0</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)54898181</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV019825373</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield><subfield code="a">DE-29T</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RS192</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.19</subfield><subfield code="2">22</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VN 7200</subfield><subfield code="0">(DE-625)147610:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Supercritical fluid technology for drug product development</subfield><subfield code="c">ed. by Peter York ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York [u.a.]</subfield><subfield code="b">Dekker</subfield><subfield code="c">2004</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XIII, 666 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Drugs and the pharmaceutical sciences</subfield><subfield code="v">138</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs - Research</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Fluides supercritiques</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Médicaments - Administration - Dispositifs - Conception</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Médicaments - Développement - Innovations</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Techniques pharmaceutiques</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">aPharmaceutical technology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">aDrug development</subfield><subfield code="a">xTechnological innovations</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">aSupercritical fluids</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">aSupercritical fluid extraction</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">aDrug delivery systems</subfield><subfield code="a">xDesign</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">aDrug Evaluation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">aDrug Design</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">aDrug Industry</subfield><subfield code="a">xorganization & administration</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">aDrugs</subfield><subfield code="a">xResearch</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Produktentwicklung</subfield><subfield code="0">(DE-588)4139402-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Überkritischer Zustand</subfield><subfield code="0">(DE-588)4186602-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Wirkstofffreisetzung</subfield><subfield code="0">(DE-588)4190018-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Therapeutisches System</subfield><subfield code="0">(DE-588)4267580-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Therapeutisches System</subfield><subfield code="0">(DE-588)4267580-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Wirkstofffreisetzung</subfield><subfield code="0">(DE-588)4190018-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Produktentwicklung</subfield><subfield code="0">(DE-588)4139402-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Überkritischer Zustand</subfield><subfield code="0">(DE-588)4186602-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">York, Peter</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Drugs and the pharmaceutical sciences</subfield><subfield code="v">138</subfield><subfield code="w">(DE-604)BV000002008</subfield><subfield code="9">138</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=013150563&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-013150563</subfield></datafield></record></collection> |
| id | DE-604.BV019825373 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T20:06:59Z |
| institution | BVB |
| isbn | 0824748050 |
| language | English |
| lccn | 2004300574 |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-013150563 |
| oclc_num | 54898181 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM DE-29T |
| owner_facet | DE-19 DE-BY-UBM DE-29T |
| physical | XIII, 666 S. Ill., graph. Darst. |
| publishDate | 2004 |
| publishDateSearch | 2004 |
| publishDateSort | 2004 |
| publisher | Dekker |
| record_format | marc |
| series | Drugs and the pharmaceutical sciences |
| series2 | Drugs and the pharmaceutical sciences |
| spelling | Supercritical fluid technology for drug product development ed. by Peter York ... New York [u.a.] Dekker 2004 XIII, 666 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Drugs and the pharmaceutical sciences 138 Drugs - Research Fluides supercritiques Médicaments - Administration - Dispositifs - Conception Médicaments - Développement - Innovations Techniques pharmaceutiques aPharmaceutical technology aDrug development xTechnological innovations aSupercritical fluids aSupercritical fluid extraction aDrug delivery systems xDesign aDrug Evaluation aDrug Design aDrug Industry xorganization & administration aDrugs xResearch Produktentwicklung (DE-588)4139402-1 gnd rswk-swf Überkritischer Zustand (DE-588)4186602-2 gnd rswk-swf Wirkstofffreisetzung (DE-588)4190018-2 gnd rswk-swf Therapeutisches System (DE-588)4267580-7 gnd rswk-swf Therapeutisches System (DE-588)4267580-7 s Wirkstofffreisetzung (DE-588)4190018-2 s Produktentwicklung (DE-588)4139402-1 s Überkritischer Zustand (DE-588)4186602-2 s DE-604 York, Peter Sonstige oth Drugs and the pharmaceutical sciences 138 (DE-604)BV000002008 138 GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=013150563&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Supercritical fluid technology for drug product development Drugs and the pharmaceutical sciences Drugs - Research Fluides supercritiques Médicaments - Administration - Dispositifs - Conception Médicaments - Développement - Innovations Techniques pharmaceutiques aPharmaceutical technology aDrug development xTechnological innovations aSupercritical fluids aSupercritical fluid extraction aDrug delivery systems xDesign aDrug Evaluation aDrug Design aDrug Industry xorganization & administration aDrugs xResearch Produktentwicklung (DE-588)4139402-1 gnd Überkritischer Zustand (DE-588)4186602-2 gnd Wirkstofffreisetzung (DE-588)4190018-2 gnd Therapeutisches System (DE-588)4267580-7 gnd |
| subject_GND | (DE-588)4139402-1 (DE-588)4186602-2 (DE-588)4190018-2 (DE-588)4267580-7 |
| title | Supercritical fluid technology for drug product development |
| title_auth | Supercritical fluid technology for drug product development |
| title_exact_search | Supercritical fluid technology for drug product development |
| title_full | Supercritical fluid technology for drug product development ed. by Peter York ... |
| title_fullStr | Supercritical fluid technology for drug product development ed. by Peter York ... |
| title_full_unstemmed | Supercritical fluid technology for drug product development ed. by Peter York ... |
| title_short | Supercritical fluid technology for drug product development |
| title_sort | supercritical fluid technology for drug product development |
| topic | Drugs - Research Fluides supercritiques Médicaments - Administration - Dispositifs - Conception Médicaments - Développement - Innovations Techniques pharmaceutiques aPharmaceutical technology aDrug development xTechnological innovations aSupercritical fluids aSupercritical fluid extraction aDrug delivery systems xDesign aDrug Evaluation aDrug Design aDrug Industry xorganization & administration aDrugs xResearch Produktentwicklung (DE-588)4139402-1 gnd Überkritischer Zustand (DE-588)4186602-2 gnd Wirkstofffreisetzung (DE-588)4190018-2 gnd Therapeutisches System (DE-588)4267580-7 gnd |
| topic_facet | Drugs - Research Fluides supercritiques Médicaments - Administration - Dispositifs - Conception Médicaments - Développement - Innovations Techniques pharmaceutiques aPharmaceutical technology aDrug development xTechnological innovations aSupercritical fluids aSupercritical fluid extraction aDrug delivery systems xDesign aDrug Evaluation aDrug Design aDrug Industry xorganization & administration aDrugs xResearch Produktentwicklung Überkritischer Zustand Wirkstofffreisetzung Therapeutisches System |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=013150563&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV000002008 |
| work_keys_str_mv | AT yorkpeter supercriticalfluidtechnologyfordrugproductdevelopment |